Regional cerebral blood flow reductions, heart failure and Alzheimer's disease

REFERENCES

• Zambroski CH. Qualitative analysis of living with heart failure. Heart Lung 2003; 32: 32–40
   PubMed Web of Science ®Google Scholar
• Zuccala G, Pedone C, Cesari M, et al. The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 2003; 115: 97–103
   PubMed Web of Science ®Google Scholar
• Almeida OP, Flicker L. The mind of a failing heart: A systematic review of the association between congestive heart failure and cognitive functioning. Intern Med J 2001; 31: 290-295
   Google Scholar
• Antonelli Incalzi R, Trojano L, Acanfora D, et al. Verbal memory impairment in congestive heart failure. J Clin Exp Neuropsychol 2003; 25: 14–23
   PubMed Web of Science ®Google Scholar
• Ackerman RH. Cerebral blood flow and neurological change in chronic heart failure. Stroke 2001; 32: 2462–2464
   PubMed Web of Science ®Google Scholar
• Gruhn N, Larsen FS, Boesgaard S, et al. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke 2001; 32: 2530–2533
   PubMed Web of Science ®Google Scholar
• de la Torre JC. Is Alzheimer&s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004; 3: 184–190
   PubMed Web of Science ®Google Scholar
• de la Torre JC. Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. Ann NY Acad Sci 2000; 924: 136–152
   PubMed Web of Science ®Google Scholar
• Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 2001; 64: 575–611
   PubMed Web of Science ®Google Scholar
• de la Torre JC. Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci Biobehav Rev 1994; 18: 397–401
   PubMed Web of Science ®Google Scholar
• Gungor HA, Yildiz A, Aydin F, et al. Tc-99m HMPAO brain SPECT findings in mild and moderate Alzheimer's disease: Correlation with event related potentials. J Neurol Sci 2005; 234: 47–53
   PubMed Web of Science ®Google Scholar
• Busatto GF, Garrido GE, Almeida OP, et al. A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer's disease. Neurobiol Aging 2003; 24: 221–231
   PubMed Web of Science ®Google Scholar
• Garrido GE, Furuie SS, Buchpiguel CA, et al. Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: A combined MRI and SPECT study. J Neurol Neurosurg Psychiatry 2002; 73: 508–516
   PubMed Web of Science ®Google Scholar
• Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann Nucl Med 2001; 15: 85–92
   PubMed Web of Science ®Google Scholar
• Bottino CM, Castro CC, Gomes RL, et al. Volumetric MRI measurements can differentiate Alzheimer's disease, mild cogni-tive impairment, and normal aging. Int Psychogeriatr 2002; 14: 59–72
   PubMed Web of Science ®Google Scholar
• Kantarci K, Jack CR, Jr. Neuroimaging in Alzheimer disease: An evidence-based review. Neuroimaging Clin N Am 2003; 13: 197–209
   PubMed Web of Science ®Google Scholar
• Laukka EJ, Jones S, Small Bi, et al. Similar patterns of cognitive deficits in the preclinical phases of vascular dementia and Alzheimer's disease. Jint Neuropsychol Soc 2004; 10: 382–391
   PubMed Web of Science ®Google Scholar
• Borroni B, Anchisi D, Paghera B, et al. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 2006; 27: 24–31
   PubMed Web of Science ®Google Scholar
• Nobili F, Brugnolo A, Calvini P, et al. Resting SPECT-neuropsy-chology correlation in very mild Alzheimer's disease. Clin Neurophysiol 2005; 116: 364–375
   PubMed Web of Science ®Google Scholar
• Reiman EM, Chen K, Alexander GE, et al. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measure-ments of regional hypometabolism. Proc Natl Acad Sci USA 2005; 102: 8299–8302
   PubMed Web of Science ®Google Scholar
• Hirao K, Ohnishi T, Hirata Y, et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 2005; 28: 1014-1021
   Google Scholar
• Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 2005; 32: 486–510
   PubMed Web of Science ®Google Scholar
• Girouard H, ladecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol 2006; 100: 328–335
   PubMed Web of Science ®Google Scholar
• van der Flier WM, Middelkoop HA, Weverling-Rijnsburger AW, et al. Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD. Neurology 2004; 62: 1862–1864
   PubMed Web of Science ®Google Scholar
• Sadowski M, Pankiewicz J, Scholtzova H, et al. Links between the pathology of Alzheimer's disease and vascular dementia. Neurochem Res 2004; 29: 1257–1266
   PubMed Web of Science ®Google Scholar
• Weller RO, Nicoll JA. Cerebral amyloid angiopathy: Pathogenesis and effects on the ageing and Alzheimer brain. Neurol Res 2003; 25: 611–616
   PubMed Web of Science ®Google Scholar
• Wais PE, Wixted JT, Hopkins RO, et al. The hippocampus supports both the recollection and the familiarity components of recognition memory. Neuron 2006; 49: 459–466
   PubMed Web of Science ®Google Scholar
• Cabeza R, Nyberg L. Imaging cognition II: An empirical review of 275 PET and fMRI studies. Cogn Neurosci 2000; 12: 1–47
   PubMed Web of Science ®Google Scholar
• Muller Mi, Greverus D, Dellani PR, et al. Functional implications of hippocampal volume and diffusivity in mild cognitive impairment. Neuroimage 2005; 28: 1033–1042
   PubMed Web of Science ®Google Scholar
• Chetelat G, Landeau B, Eustache F, et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study. Neuroimage 2005; 27: 934–946
   PubMed Web of Science ®Google Scholar
• Dickerson BC, Salat DH, Bates JF, et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 2004; 56: 27–35
   PubMed Web of Science ®Google Scholar
• Mungas D, Reed BR, Jagust WJ, et al. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 2002; 59: 867–873
   PubMed Web of Science ®Google Scholar
• Zakzanis KK, Graham Si, Campbell Z. A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: A neuroimaging profile. Neuropsychol Rev 2003; 13: 1–18
   PubMed Web of Science ®Google Scholar
• Ylikoski R, Salonen O, Mantyla R, et al. Hippocampal and temporal lobe atrophy and age-related decline in memory. Acta Neurol Scand 2000; 101: 273–278
   PubMed Web of Science ®Google Scholar
• Grundman M, Sencakova D, Jack CR, Jr., et al. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci 2002; 19: 23–27
   PubMed Web of Science ®Google Scholar
• Matsuda H, Kanetaka H, Ohnishi T, et al. Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction. Eur J Nucl Med Mol Imaging 2002; 29: 1502–1505
   PubMed Web of Science ®Google Scholar
• Mielke R, Heiss WD. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia. J Neural Transm Suppl 1998; 53: 237–250
   PubMedGoogle Scholar
• Kerrouche N, Herholz K, Mielke R, et al. (18)FDG PET in vascular dementia: Differentiation from Alzheimer's disease using voxel-based multivariate analysis. J Cereb Blood Flow Metab 2006;
   Google Scholar
• Nagata K, Maruya H, Yuya H, et al. Can PET data differentiate Alzheimer's disease from vascular dementia? Ann NY Acad Sci 2000; 903: 252–261
   PubMed Web of Science ®Google Scholar
• Testa C, Laakso MP, Sabattoli F, et al. A comparison between the accuracy of voxel-based morphometry and hippocampal volu-metry in Alzheimer's disease. J Magn Reson Imaging 2004; 19: 274–282
   PubMed Web of Science ®Google Scholar
• Colloby Si, O'Brien JT, Fenwick JD, et al. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease. Neuroimage 2004; 23: 956–966
   PubMed Web of Science ®Google Scholar
• Varrone A, Pappata S, Caraco C, et al. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks. Eur J Nucl Med Mol Imaging 2002; 29: 1447–1454
   PubMed Web of Science ®Google Scholar
• Ishii K, Sasaki M, Yamaji S, et al. Demonstration of decreased posterior cingulate perfusion in mild Alzheimer's disease by means of H2150 positron emission tomography. Eur J Nucl Med 1997; 24: 670–673
   PubMedGoogle Scholar
• Liao YC, Liu RS, Lee YC, et al. Selective hypoperfusion of anterior cingulate gyrus in depressed AD patients: A brain SPECT finding by statistical parametric mapping. Dement Geriatr Cogn Disord 2003; 16: 238–244
   PubMed Web of Science ®Google Scholar
• Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985–1992
   PubMed Web of Science ®Google Scholar
• Reiman EM, Chen K, Alexander GE, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004; 101: 284–289
   PubMed Web of Science ®Google Scholar
• Reiman EM, Uecker A, Caselli RJ, et al. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 1998; 44: 288–291
   PubMed Web of Science ®Google Scholar
• Mosconi L, Sorbi S, Nacmias B, et al. Age and ApoE genotype interaction in Alzheimer's disease: An FDG-PET study. Psychiatry Res 2004; 130: 141–151
   PubMed Web of Science ®Google Scholar
• Hoffman JM, Welsh-Bohmer KA, Hanson M, et al. FDG PET imaging in patients with pathologically verified dementia. J Nucl Med 2000; 41: 1920–1928
   PubMed Web of Science ®Google Scholar
• Desgranges B, Baron JC, de la Sayette V, et al. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain 1998; 121 (Pt 4): 611–631
   PubMed Web of Science ®Google Scholar
• Desgranges B, Baron JC, Giffard B, et al. The neural basis of intrusions in free recall and cued recall: A PET study in Alzheimer's disease. Neuroimage 2002; 17: 1658–1664
   PubMed Web of Science ®Google Scholar
• Kessler RM. Imaging methods for evaluating brain function in man. Neurobiol Aging 2003; 24 (Suppl. 1): S21—S35
   Google Scholar
• Jonsson C, Pagani M, Ingvar M, et al. Resting state rCBF mapping with single-photon emission tomography and positron emission tomography: Magnitude and origin of differences. Eur J Nucl Med 1998; 25: 157–165
   PubMedGoogle Scholar
• Kogure D, Matsuda H, Ohnishi T, et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000; 41:1155–1162
   PubMed Web of Science ®Google Scholar
• Woo MA, Macey PM, Fonarow GC, et al. Regional brain gray matter loss in heart failure. J Appl Physiol 2003; 95: 677–684
   PubMed Web of Science ®Google Scholar
• Woo MA, Macey PM, Keens PT, et al. Functional abnormalities in brain areas that mediate autonomic nervous system control in advanced heart failure. J Card Fail 2005; 11: 437–446
   PubMed Web of Science ®Google Scholar
• Lee CW, Lee JH, Lim TH, et al. Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure. Circulation 2001; 103: 2784–2787
   PubMed Web of Science ®Google Scholar
• Lee CW, Lee JH, Kim JJ, et al. Cerebral metabolic abnormalities in congestive heart failure detected by proton magnetic resonance spectroscopy. J Am Coll Cardiol 1999; 33: 1196–1202
   PubMed Web of Science ®Google Scholar
• Lassen NA, Larsen OA. Measurement of blood flow with freely diffusible indicators as inert gases, antipyrine, labelled water and rubidium. Acta Endocrinol Suppl (Copenh) 1972; 158: 95–111
   PubMedGoogle Scholar
• Georgiadis D, Sievert M, Cencetti S, et al. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart] 2000; 21: 407–413
   PubMed Web of Science ®Google Scholar
• Rajagopalan B, Raine AE, Cooper R, et al. Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment. Am] Med 1984; 76: 86–90
   PubMed Web of Science ®Google Scholar
• Paulson OB, Jarden JO, Godtfredsen J, et al. Cerebral blood flow in patients with congestive heart failure treated with captopril. Am J Med 1984; 76: 91–95
   PubMed Web of Science ®Google Scholar
• Wanless RB, Anand IS, Poole-Wilson PA, et al. An experimental model of chronic cardiac failure using adriamycin in the rabbit: Central haemodynamics and regional blood flow. Cardiovasc Res 1987; 21: 7–13
   PubMed Web of Science ®Google Scholar
• Wanless RB, Anand IS, Gurden J, et al. Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: Effects of isosorbide dinitrate, dobutamine and captopril. J Pharmacol Exp Ther 1987; 243: 1101–1106
   PubMed Web of Science ®Google Scholar
• Costa DC, Verhoeff NP, Cullum ID, et al. In vivo characterisation of 3-iodo-6-methoxybenzamide 1231 in humans. Eur J Nucl Med 1990; 16: 813–816
   PubMedGoogle Scholar
• Neirinckx RD. Evaluation of regional cerebral blood flow with 99mTc-d, 1 HM-PAO and SPECT. Neurosurg Rev 1987; 10: 181–184
   PubMed Web of Science ®Google Scholar
• Alves TC, Rays J, Fraguas R, Jr., et al. Localized cerebral blood flow reductions in patients with heart failure: A study using 99mTc-HMPAO SPECT. J Neuroimaging 2005; 15: 150–156
   PubMed Web of Science ®Google Scholar
• Zuccala G, Cattel C, Manes-Gravina E, et al. Left ventricular dysfunction: A clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 1997; 63: 509–512
   PubMed Web of Science ®Google Scholar
• Grubb NR, Simpson C, Fox KA. Memory function in patients with stable, moderate to severe cardiac failure. Am Heart] 2000; 140: 1–5
   PubMedGoogle Scholar
• Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986; 149: 698–709
   PubMed Web of Science ®Google Scholar
• Almeida OP, Tamai S. Clinical treatment reverses attentional deficits in congestive heart failure. BMC Geriatr 2001; 1: 2
   PubMedGoogle Scholar
• Pansari K, Gupta A, Thomas P. Alzheimer&s disease and vascular factors: Facts and theories. Int.' Clin Pract 2002; 56: 197–203
   PubMed Web of Science ®Google Scholar
• Polidori MC, Marvardi M, Cherubini A, et al. Heart disease and vascular risk factors in the cognitively impaired elderly: Implications for Alzheimer's dementia. Aging (Milano) 2001; 13: 231–239
   PubMedGoogle Scholar
• Rafael H. Cerebral atherosclerosis and mild Alzheimer's disease. Stroke 2003; 34: e106
   Google Scholar
• Honig LS, Tang MX, Albert S, et al. Stroke and the risk of Alzheimer disease. Arch Neurol 2003; 60: 1707–1712
   PubMedGoogle Scholar
• Roman GC, Kalaria RN. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging 2005;
   Google Scholar
• Solfrizzi V, Panza F, Colacicco AM, et al. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004; 63: 1882–1891
   PubMed Web of Science ®Google Scholar
• Schnaider Been i M, Goldbourt U, Silverman JM, et al. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology 2004; 63: 1902–1907
   PubMed Web of Science ®Google Scholar
• Roher AE, Esh C, Rahman A, et al. Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke 2004; 35: 2623–2627
   PubMed Web of Science ®Google Scholar
• Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke 2004; 35 (Suppl. 1): S2620—S2622
   Google Scholar
• Wang L, Zang Y, He Y, et al. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: Evidence from resting state fMRI. Neuroimage 2006; 31: 496–504
   PubMed Web of Science ®Google Scholar
• Buckner RL, Snyder AZ, Shannon BJ, et al. Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005; 25: 7709–7717
   PubMed Web of Science ®Google Scholar
• Blaizot X, Meguro K, Mil lien I, et al. Correlations between visual recognition memory and neocortical and hippocampal glucose metabolism after bilateral rhinal cortex lesions in the baboon: Implications for Alzheimer's disease.] Neurosci 2002; 22: 9166–9170
   Google Scholar
• Chavoix C, Blaizot X, Meguro K, et al. Excitotoxic lesions of the rhinal cortex in the baboon differentially affect visual recognition memory, habit memory and spatial executive functions. Eur J Neurosci 2002; 15: 1225–1236
   PubMed Web of Science ®Google Scholar
• Millien I, Blaizot X, Giffard C, et al. Brain glucose hypometabo-lism after perirhinal lesions in baboons: Implications for Alzheimer disease and aging. J Cereb Blood Flow Metab 2002; 22: 1248–1261
   PubMed Web of Science ®Google Scholar
• Buckner RL. Memory and executive function in aging and AD: Multiple factors that cause decline and reserve factors that compensate. Neuron 2004; 44: 195–208
   PubMed Web of Science ®Google Scholar
• Meguro K, Blaizot X, Kondoh Y, et al. Neocortical and hippocampal glucose hypometabol ism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. Brain 1999; 122 (Pt 8): 1519-1531
   Google Scholar
• Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306–319
   PubMed Web of Science ®Google Scholar
• Baron JC, Chetelat G, Desgranges B, et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001; 14: 298–309
   PubMed Web of Science ®Google Scholar
• Good CD, Scahil I RI, Fox NC, et al. Automatic differentiation of anatomical patterns in the human brain: Validation with studies of degenerative dementias. Neuroimage 2002; 17: 29–46
   PubMed Web of Science ®Google Scholar
• Thompson PM, Hayashi KM, de Zubicaray G, et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 2003; 23: 994–1005
   PubMed Web of Science ®Google Scholar
• Wang Y, Klunk WE, Debnath ML, et al. Development of a PET/ SPECT agent for amyloid imaging in Alzheimer's disease. J Mol Neurosci 2004; 24: 55–62
   PubMed Web of Science ®Google Scholar
• Farkas E, De Jong GI, Apro E, et al. Similar ultrastructural breakdown of cerebrocortical capillaries in Alzheimer's disease, Parkinson's disease, and experimental hypertension. What is the functional link? Ann NY Acad Sci 2000; 903: 72–82
   PubMed Web of Science ®Google Scholar
• Farkas E, De Jong GI, de Vos RA, et al. Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease. Acta Neuropathol (Berl) 2000; 100: 395–402
   PubMed Web of Science ®Google Scholar
• Freedland KE, Rich MW, Skala JA, et al. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 2003; 65:119–128
   PubMed Web of Science ®Google Scholar
• Thomas SA, Friedmann E, Khatta M, et al. Depression in patients with heart failure: Physiologic effects, incidence, and relation to mortality. AACN Clin Issues 2003; 14: 3–12
   PubMedGoogle Scholar
• Junger J, Schellberg D, Muller-Tasch T, et al. Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail 2005; 7: 261–267
   PubMed Web of Science ®Google Scholar
• Roose SP. Depression, anxiety, and the cardiovascular system: The psychiatrist's perspective. J Clin Psychiatry 2001; 62 (Suppl. 8): 19-22
   Google Scholar
• Alves TC, Rays J, Telles RM, et al. Effects of antidepressant treatment on cognitive performance in elderly subjects with heart failure and comorbid major depression: An exploratory study. Psychosomatics 2006; in press
   Google Scholar
• Alves TC, Rays J, Fraguas Jr R, et al. Association between major depressive symptoms in heart failure and impaired regional cerebral blood flow in the medial temporal region: A study using 99m Tc-HMPAO single photon emission computerized tomo-graphy (SPECT). Psychol Med 2006; 36: 597–608
   PubMed Web of Science ®Google Scholar
• Campbell S, Marriott M, Nahmias C, et al. Lower hippocampal volume in patients suffering from depression: A meta-analysis. Am J Psychiatry 2004; 161: 598–607
   PubMed Web of Science ®Google Scholar
• Drevets WC, Price JL, Bardgett ME, et al. Glucose metabolism in the amygdala in depression: Relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav 2002; 71: 431–447
   PubMed Web of Science ®Google Scholar
• Phillips ML, Drevets WC, Rauch SL, et al. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry 2003; 54: 515–528
   PubMed Web of Science ®Google Scholar
• Krishnan KR. Biological risk factors in late life depression. Biol Psychiatry 2002; 52: 185–192
   PubMed Web of Science ®Google Scholar
• O'Brien JT, Lloyd A, McKeith I, et al. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am Psychiatry 2004; 161: 2081–2090
   PubMed Web of Science ®Google Scholar
• Seminowicz DA, Mayberg HS, McIntosh AR, et al. Limbic-frontal circuitry in major depression: A path modeling metanalysis. Neuroimage 2004; 22: 409–418
   PubMed Web of Science ®Google Scholar
• Marvel CL, Paradiso S. Cognitive and neurological impairment in mood disorders. Psychiatr Clin North Am 2004; 27: 19-36, vii—viii
   Google Scholar
• Cummings JL. Alzheimer's disease: From molecular biology to neuropsych iatry. Semin Clin Neuropsychiatry 2003; 8: 31–36
   PubMedGoogle Scholar
• Haan MN, Wallace R. Can dementia be prevented? Brain aging in a population-based context. Annu Rev Public Health 2004; 25: 1–24
   PubMed Web of Science ®Google Scholar
• Cummings JL. Cognitive and behavioral heterogeneity in Alzheimer's disease: Seeking the neurobiological basis. Neurobiol Aging 2000; 21: 845–861
   PubMed Web of Science ®Google Scholar
• Modrego PJ, Fayed N, Pina MA. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Am J Psychiatry 2005; 162: 667–675
   PubMed Web of Science ®Google Scholar
• Paulson OB, Jarden JO, Vorstrup S, et al. Effect of captopril on the cerebral circulation in chronic heart failure. Eur J Clin Invest 1986; 16: 124–132
   PubMed Web of Science ®Google Scholar
• Kamishirado H, Inoue T, Fujito T, et al. Effect of enalapril maleate on cerebral blood flow in patients with chronic heart failure. Angiology 1997; 48: 707–713
   PubMed Web of Science ®Google Scholar
• Massaro AR, Dutra AP, Almeida DR, et al. Transcranial Doppler assessment of cerebral blood flow: Effect of cardiac transplanta-tion. Neurology 2006; 66: 124–126
   PubMed Web of Science ®Google Scholar
• Talairach J, Tornoux P. A Co-planaR Stereotaxic Atlas of Human Brain, Stuttgart, Germany: Thieme, 1988
   Google Scholar